Head of Strategy END RHD; Senior Technical Adviser
MBChB MPH FRACGP
Dr Rosemary Wyber completed her medical degree in New Zealand, her Masters of Public Health at the Harvard School of Public Health and her General Practice registrar training in the Northern Territory. Her research interests are rheumatic heart disease and diseases of disparity in vulnerable populations. Rosemary is a Senior Adjunct Research Fellow at the University of Western Australia and the Head of Strategy for END RHD.
- Projects
-
Publications
June 2018
Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD)
The current prophylactic treatment to prevent rheumatic heart disease requires four-weekly intramuscular injection of a suspension of the poorly soluble benzathine salt form of penicillin G (BPG) often for more than 10 years. In seeking to reduce the frequency of administration to improve adherence, biodegradable polymer matrices have been investigated.
Published research Group A Streptococcal & Rheumatic Heart DiseaseNovember 2017Rheumatic heart disease: infectious disease origin, chronic care approach.
Rheumatic heart disease (RHD) is a chronic cardiac condition with an infectious aetiology, causing high disease burden in low-income settings.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseOctober 2017The rationale for action to end new cases of rheumatic heart disease in Australia
The choice of RHD is telling: the disease is a marker of inequality, a novel lens for considering health systems and a feasible target for disease control.
Published research Aboriginal Health & Wellbeing Group A Streptococcal & Rheumatic Heart DiseaseMarch 2016The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of Rheumatic Heart Disease
As a general guide, the Roadmap is meant to serve as the foundation for the development of tailored plans of action to improve RHD control in specific contexts.
Published research Human Immunology Group A Streptococcal & Rheumatic Heart DiseaseMarch 2017A Comprehensive Needs Assessment Tool for Planning Rheumatic Heart Disease Control Programs in Limited Resource Settings
RHD is an important cause of disability and death in low- and middle-income countries.
Published research Group A Streptococcal & Rheumatic Heart DiseaseJanuary 2017Rheumatic heart disease across the Western Pacific: not just a Pacific Island problem
We aimed to review RHD burden in Western Pacific Region outside Oceania to identify countries with high RHD burden
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseOctober 2016Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever
A sample target product profile for reformulated benzathine penicillin G is presented
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseFebruary 2016Myositis complicating benzathine penicillin-G injection in a case of rheumatic heart disease
A 7-year old boy developed myositis secondary to intramuscular injection of benzathine penicillin-G in the context of secondary prophylaxis for RF
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseAugust 2015Supply of benzathine penicillin G: the 20-year experience in Australia
Reliable supplies of BPG are essential for delivering the recommended schedule of secondary prophylaxis for people living with RHD.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseJuly 2015Rheumatic heart disease among adults in a mining community of Papua, Indonesia: findings from an occupational cohort
To describe the pattern of RHD occurrence in a sample of presenting cases from an occupational cohort in Papua Province, Indonesia.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseJune 2015Treating trade: the case for clinical engagement with regional trade agreements
The global burden of non-communicable diseases (NCDs) continues to grow. Although developing settings face fastest growth in incidence, no country is exempt.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseMay 2015Evolution, Evidence and Effect of Secondary Prophylaxis Against Rheumatic Fever
The association between group A streptococcal infection and rheumatic fever (RF) was established in the early 20th century.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseMarch 2015Rheumatic heart disease: Tools for implementing programmes
This article discusses the World Health Organization program for monitoring & managing rheumatic heart disease.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseMarch 2015The 5 × 5 path toward rheumatic heart disease control: Outcomes from the third rheumatic heart disease forum
This editorial viewpoint regarding the outcomes from the third global Rheumatic Heart Disease Forum intends to carry forward dialogue & engage new...
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseJanuary 2015Big data in global health: Improving health in low- and middle-income countries
Over the last decade, a massive increase in data collection and analysis has occurred in many fields.
Published research Group A Streptococcal & Rheumatic Heart DiseaseSeptember 2014The case for global investment in rheumatic heart-disease control
The review built a case for extending simple and cost–effective measures to all countries. Had these recommendations been put into action, significant...
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseSeptember 2013The second rheumatic heart disease forum report
Building on the foundation of the first RHD forum, over 150 interested participants met to discuss critical issues on the RHD landscape.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseSeptember 2013Benzathine penicillin G for the management of RHD: Concerns about quality and access, and opportunities for intervention and improvement
Benzathine penicillin G is an important antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and...
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseSeptember 2013A conceptual framework for comprehensive rheumatic heart disease control programs
The World Health Organization, World Heart Federation, and other organizations recommend comprehensive control programs for rheumatic fever (RF) and...
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseSeptember 2013Prevention of rheumatic fever and heart disease: Nepalese experience
Historically, many young people suffered severe valvular disease and died awaiting heart valve replacement.
Published research Rheumatic Heart Disease Group A Streptococcal & Rheumatic Heart DiseaseMay 2013Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease
In the 21st century, rheumatic fever (RF) and rheumatic heart disease (RHD) are neglected diseases of marginalized communities.
Published research Immunisation Rheumatic Heart Disease Infectious Diseases Group A Streptococcal & Rheumatic Heart Disease